Elena Taborga Díaz
Research Subjects
Research Interests
Elena Taborga Díaz has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Auxiliadora Fernández de Alba
Instituto Hispalense de Pediatría, Seville, Spain
1 shared publication - Bruno Herrera
Medical Affairs Department, MSD Spain, Madrid, Spain
1 shared publication Carmen Cebrián Muíños
Complejo Asistencial Universitario de Salamanca, Salamanca, España
1 shared publicationCristina Suárez Castañón
Hospital del Oriente, Área Sanitaria VI, Arriondas, España
1 shared publication- Ignacio Salamanca de la Cueva
Instituto Hispalense de Pediatría
1 shared publication - Inés Cabeza
Healthcare Centre Galdakao, Vizcaya, Spain
1 shared publication
Latest Publications
- Open Access
- 17 November 2022
- Published by Springer Nature in Infectious Agents and Cancer
- Vol. 17 (1) , 1-11
HPV knowledge and vaccine acceptability: a survey-based study among parents of adolescents (KAPPAS study)
Background: Human papillomavirus (HPV) infection is recognized as one of the major causes of infection-related cancer worldwide. In Spain, the HPV vaccination program started in 2007 and until 2022, it targeted 12-year-old girls. Methods: This was a cross-sectional, multicenter survey-based research carried out at 24 pediatric offices to describe HPV knowledge and vaccine acceptability in parents of children aged between 9 and 14 years-old in Spain. Parents were randomly selected from the medical records following specific quotas to ensure representativeness. The survey included five sections that aim to collect information about sociodemographic characteristics, knowledge of HPV, knowledge and acceptability of vaccines in general, HPV vaccination knowledge and HPV vaccine acceptability. Each section was constituted by a number of close questions with different answer options. Specific scores were assigned to each possible answer to these questions. Based on these scores, four composite variables were created to assess HPV knowledge, HPV vaccine knowledge, HPV vaccine acceptability and vaccines knowledge and acceptability in general. A latent class analysis was performed to identify different group of respondents according to their HPV vaccine acceptability. Results: A total of 1405 valid surveys were included, with 86.19% of the respondents being mothers. The mean score of HPV knowledge was 28.92 out of 40 (maximum value) (95% CI 28.70–29.20) and the mean score of HPV vaccine acceptability was 3.37 out of 5 (maximum value). One third of parents still need more information to take a final decision about HPV vaccination in their children. Parents perceived that females were more likely to become infected than males and tended to associate HPV infection mainly with cervical cancer, showing a. a lack of information about other HPV-related diseases affecting males. Conclusions: This study results highlight the need for future actions and educational initiatives to raise awareness of HPV consequences in both genders and to contribute to achieving the elimination of HPV-related diseases beyond cervical cancer.
- 17 November 2022
- Published by Springer Nature in Infectious Agents and Cancer
- Vol. 17 (1) , 1-11
Open AccessHPV knowledge and vaccine acceptability: a survey-based study among parents of adolescents (KAPPAS study)
Background: Human papillomavirus (HPV) infection is recognized as one of the major causes of infection-related cancer worldwide. In Spain, the HPV vaccination program started in 2007 and until 2022, it targeted 12-year-old girls. Methods: This was a cross-sectional, multicenter survey-based research carried out at 24 pediatric offices to describe HPV knowledge and vaccine acceptability in parents of children aged between 9 and 14 years-old in Spain. Parents were randomly selected from the medical records following specific quotas to ensure representativeness. The survey included five sections that aim to collect information about sociodemographic characteristics, knowledge of HPV, knowledge and acceptability of vaccines in general, HPV vaccination knowledge and HPV vaccine acceptability. Each section was constituted by a number of close questions with different answer options. Specific scores were assigned to each possible answer to these questions. Based on these scores, four composite variables were created to assess HPV knowledge, HPV vaccine knowledge, HPV vaccine acceptability and vaccines knowledge and acceptability in general. A latent class analysis was performed to identify different group of respondents according to their HPV vaccine acceptability. Results: A total of 1405 valid surveys were included, with 86.19% of the respondents being mothers. The mean score of HPV knowledge was 28.92 out of 40 (maximum value) (95% CI 28.70–29.20) and the mean score of HPV vaccine acceptability was 3.37 out of 5 (maximum value). One third of parents still need more information to take a final decision about HPV vaccination in their children. Parents perceived that females were more likely to become infected than males and tended to associate HPV infection mainly with cervical cancer, showing a. a lack of information about other HPV-related diseases affecting males. Conclusions: This study results highlight the need for future actions and educational initiatives to raise awareness of HPV consequences in both genders and to contribute to achieving the elimination of HPV-related diseases beyond cervical cancer.
- Open Access
- 1 August 2021
- Published by Elsevier in Anales de Pediatría
- Vol. 95 (2) , 101-107
Valoración de los criterios diagnósticos de la enuresis nocturna
- 1 August 2021
- Published by Elsevier in Anales de Pediatría
- Vol. 95 (2) , 101-107
Open AccessValoración de los criterios diagnósticos de la enuresis nocturna